Eric Deng
Hoofd Techniek/Wetenschap/O&O bij MEI PHARMA, INC.
Oorsprong van het eerstegraads netwerk van Eric Deng
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 27 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Eric Deng via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| HERON THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Public Communications Contact | |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Public Communications Contact | |
DNA Sciences, Inc.
 DNA Sciences, Inc. Medical SpecialtiesHealth Technology Part of AbbVie, Inc., DNA Sciences, Inc. is a company that develops and produces in vitro diagnostic and research reagent products. The company is based in Fremont, CA. The company was founded by Hugh Young Rienhoff. DNA Sciences was acquired by Genaissance Pharmaceuticals, Inc., part of AbbVie, Inc. from October 07, 2005 on April 01, 2003 for $1.30 million. | Medical Specialties | General Counsel | |
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Biotechnology | Chief Executive Officer | |
InSight Health Corp.
 InSight Health Corp. Medical/Nursing ServicesHealth Services InSight Health Corp. provides diagnostic imaging and therapeutic healthcare services. It provides services to patients, physicians, managed care entities, hospitals and other contractual customers. The company was founded in 1996 and is headquartered in St. Louis Park, MN. | Medical/Nursing Services | Comptroller/Controller/Auditor | |
InSight Health Services Holdings Corp.
 InSight Health Services Holdings Corp. Medical/Nursing ServicesHealth Services Insight Health Services Holdings Corp. provides fixed site and mobile diagnostic imaging services. It offers magnetic resonance imaging, computed and positron emission tomography, as well as other radiological services. The company was founded in 2001 and is headquartered in St. Louis Park, MN. | Medical/Nursing Services | Comptroller/Controller/Auditor | |
JSB-Partners LP
 JSB-Partners LP Investment Banks/BrokersFinance JSB-Partners LP offers specialized investment banking and advisory services to biotechnology and pharmaceutical companies. Its services include product partnerships, mergers and acquisitions, private placements and public underwritings. The company was founded by Wolfgang Rudolph Ralph Stoiber in 1999 and is headquartered in Boston, MA. | Investment Banks/Brokers | Corporate Officer/Principal | |
Genoptix, Inc.
 Genoptix, Inc. Medical SpecialtiesHealth Technology Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA. | Medical Specialties | Director/Board Member | |
Tioga Pharmaceuticals, Inc.
 Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tioga Pharmaceuticals, Inc. manufactures pharmaceutical products. It develops therapies for the treatment of pruritus. The company was founded by Stuart J. Collinson in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder | |
| HEPION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Chief Investment Officer | |
Scripps Memorial Hospital La Jolla
 Scripps Memorial Hospital La Jolla Managed Health CareHealth Services Part of Scripps Memorial Hospitals, Scripps Memorial Hospital La Jolla is a community based health care network. The company is based in La Jolla, CA. | Managed Health Care | Corporate Officer/Principal | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| The Reed Institute | College/University | Undergraduate Degree | |
| San Diego State University | College/University | Undergraduate Degree Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Doctorate Degree | |
| Franklin & Marshall College | College/University | Undergraduate Degree | |
| University of British Columbia | College/University | Graduate Degree | |
| University of San Diego | College/University | Undergraduate Degree | |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Investor Relations Contact | |
Actavis Pharma, Inc.
 Actavis Pharma, Inc. Drugstore ChainsRetail Trade Actavis Pharma, Inc. develops, manufactures, and markets pharmaceutical products. It offers solid dosage and sterile dosage generic products. The company is headquartered in Morristown, NJ. | Drugstore Chains | Director/Board Member | |
| Brooklyn Law School | College/University | Graduate Degree | |
| BIOLINERX LTD. | Pharmaceuticals: Major | Director/Board Member | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
Sidney Kimmel Cancer Center
 Sidney Kimmel Cancer Center Medical/Nursing ServicesHealth Services Part of Sanford Burnham Prebys Medical Discovery Institute, Sidney Kimmel Cancer Center provides medical research services. The company is based in San Diego, CA. Sidney Kimmel Cancer Center was acquired by Sanford Burnham Prebys Medical Discovery Institute on June 23, 2009 for $25 million. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ENZYMOTEC LTD. | Biotechnology | Director/Board Member | |
The Hope Funds for Cancer Research
 The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| New York University School of Law | College/University | Graduate Degree | |
| CUE BIOPHARMA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Scientus Pharma, Inc.
 Scientus Pharma, Inc. Agricultural Commodities/MillingProcess Industries Scientus Pharma, Inc. provides biopharmaceutical products extracted from the cannabis plant. The private company is based in Whitby, Canada. | Agricultural Commodities/Milling | Director/Board Member | |
| Howson Associates Ltd. | Corporate Officer/Principal | ||
Pattern Pharma, Inc.
 Pattern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pattern Pharma, Inc. engages in the pharmaceutical industry. Its product named P2PAR addresses the immune failure which underlies infectious diseases and cancers. The company is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| IMMUNIC, INC. | Pharmaceuticals: Major | Director/Board Member | |
| IMMUNITYBIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 39 |
| Canada | 8 |
| Verenigd Koninkrijk | 3 |
| Israël | 3 |
| Duitsland | 2 |
Sectoraal
| Health Technology | 30 |
| Consumer Services | 10 |
| Health Services | 5 |
| Finance | 4 |
| Commercial Services | 3 |
Operationeel
| Director/Board Member | 92 |
| Corporate Officer/Principal | 57 |
| Independent Dir/Board Member | 42 |
| Undergraduate Degree | 24 |
| Chief Tech/Sci/R&D Officer | 18 |
Sterkste connecties
| Insiders | |
|---|---|
| Tamar Howson | 41 |
| Fred Driscoll | 21 |
| Cheryl Cohen | 20 |
| Charles Baltic | 15 |
| Richard Ghalie | 13 |
| Steven Wood | 12 |
| Christine Anna White | 11 |
| Sujay Kango | 10 |
| Thomas Reynolds | 10 |
| Nick Glover | 10 |
| Tina Beamon | 9 |
| David Urso | 9 |
| David Walsey | 9 |
| Daniel Gold | 9 |
| Kevan E. Clemens | 8 |
